ABI Biennial Conference on Wednesday (22 June) to find out more about a possible delay in the implementation of Solvency II, you were not completely disappointed. You did, however, have to wait for the penultimate question of the final Q&A session of the day. While Thursday’s news of a possible one year delay came as little surprise to many, in what can best be described as the industry’s worst kept secret, it causes more uncertainty than clarity.
What if you’re not ready for Solvency II?
[caption id="attachment_1899" align="alignright" width="152"]
The deadline is dead, long live the deadline
[caption id="attachment_1905" align="alignleft" width="264"]
Winners and losers of a Solvency II delay
Solvency II has been subject to a number of delays and ambiguities since its inception and the industry is having to, yet again, readjust to the shifting goal posts. As the Milliman report concludes, “While the change in timeframe may give both companies and supervisors welcome breathing space to design and implement their Solvency II plans, we note any resulting delay to the IMAP process may be a cause for concern amongst companies already well advanced in this area.”
Effects on the UK insurance industry

The biggest losers?
Implementing this far-reaching regulation was always going to be a challenge. Delays and uncertainty are an inevitability of such a complex process. But it is essential that regulators do not lose track of the ultimate goal. Solvency II aims to increase consumer protection and reduce costs through harmonisation. As Mr Irving notes, for the UK the former may not be the case. “One of the biggest losers from this delay would be consumers and corporates reliant on the UK insurance industry, as the costs are likely to be passed on to them.” For a regulation that has consumers at its core, this would be an undesirable outcome. [caption id="attachment_1896" align="aligncenter" width="1441"]